Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism

AAPS PharmSciTech - Switzerland
doi 10.1208/s12249-015-0377-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Development of Eudragit® NM-Based Controlled-Release Matrix Tablets

Medicina
Medicine
2012English

Formulation and in Vitro Evaluation of Theophylline-Eudragit® Sustained-Release Tablets

Revista Brasileira de Ciências Farmacêuticas
2005English

In Vitro Study of the Cytotoxic and Genotoxic Effects of Indomethacin-Loaded Eudragit® L 100 Nanocapsules

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

Desloratadine-Eudragit® RS100 Nanoparticles: Formulation and Characterization

Turkish Journal of Pharmaceutical Sciences
Molecular MedicinePharmaceutical Science
2017English

Design and in Vitro Evaluation of Eudragit-Based Extended Release Diltiazem Microspheres for Once- And Twice-Daily Administration: The Effect of Coating on Drug Release Behavior

Turkish Journal of Pharmaceutical Sciences
Molecular MedicinePharmaceutical Science
2019English

Isopar L Release From Saltstone Cured at 55 C

2006English

Electron Microscopy Investigations on Catalyst Coatings

Microscopy and Microanalysis
Instrumentation
2015English

Diffusion-Controlled Drug Release From the Mesoporous Magnesium Carbonate Upsalite ®

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2016English

Indomethacin-Containing Interpolyelectrolyte Complexes Based on Eudragit ® E PO/S 100 Copolymers as a Novel Drug Delivery System

International Journal of Pharmaceutics
Pharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy